LATEST NEWS

Contacting Brazilian Regulatory Agencies – ANVISA, INMETRO e ANATEL

Date: 09/20/2019

ANVISA recently opened a new communication channel and our team prepared an update on all the available resources for contacting Brazilian key Regulatory Agencies, concerning medical devices. Knowing how to reach out to the agencies can help if you intend on entering the Brazilian Market.

ANVISA

Central de Atendimento / Call Center

The phone number 0800 642 9782 is available on weekdays from 7h30 to 19h30 (except for holidays). General information about ANVISA’s services are immediately available through their database that contains a variety of the most common queries. In case the information needed isn’t available, ANVISA will provide the answer within 15 working days.

The information available on ANVISA’s database is also accessible on their website.

Webchat

Webchats were recently made available by ANVISA and can be used to reach out to ANVISA online and get prompt answers. The service is available on weekdays, from 7h30 to 19h30, and it is recommended for general queries.  In case the information needed isn’t available, ANVISA will provide the answer within 15 working days.

Formulário Eletrônico / Contact Form

Using the Contact Form on their website is recommended for specific/technical queries. The form allows you to attach files related to your query in order to clarify technical issues with ANVISA technical sectors. ANVISA will provide the answer within 15 working days.

Ouvidoria / Ombuds Office 

The Ombuds Office is the proper channel to report a situation and/or express   complaints, suggestions, requests and compliments. An online form is available on their website and the answer can take up to 15 working days.

Audiências / Audience

A space called Parlatório is available for meetings between ANVISA and the community. Using the online form available on their website you can request a meeting with an specific area of ANVISA, informing the subject of the meeting. The request must be submitted at least 10 working days before the proposed meeting date. You also have the option of requesting an online Skype meeting.

Serviço de Informação ao Cidadão (SIC) / Citizen Information Service

Face-to-face service available at ANVISA’s headquarters, in Brasília, on weekdays from 8h to 18h, no previous appointment needed. Depending on the query, ANVISA might take up to 15 working days to provide the answer.

A Customer Satisfaction Survey is conducted by ANVISA every year in order to get feedback from citizens who attended the service and identify weak aspects and possible changes. The results are published on their website.

Contacting ANVISA in English and/or Spanish

There is an exclusive online form available on their website to receive queries in foreign languages – preferably Spanish or English.

 

INMETRO

Fale Conosco / Contact us

INMETRO provides five phone numbers in different Brazilian States: Rio de Janeiro, Rio Grande do Sul, Goiás and Brasília.

Perguntas Frequentes / FAQ

Available on their website list of frequently asked questions received through the Ombuds Office.

Ouvidoria / Ombuds Office

The Ombuds Office is the proper channel to report a situation and/or express   complaints, suggestions, requests and compliments. The Office operates online through a government platform called Fala.BR.

There is also a contact number (0800 285 1818) available Monday to Friday, from 9h to 17h.  Queries can also mailed or delivered to INMETRO’s office in Rio de Janeiro on weekdays from 8h to 17h.

Complaints can be sent by e-mail to saccgcre@inmetro.gov.br.

Carta de Serviços / Services Menu

INMETRO provides, for online consultation or download, a list of the services and activities performed by the Institute. Details concerning timeframes, reaching out to the Institute and standards defined by INMETRO are all presented in the document.

ANATEL

Internet

The online service channel is recommended to report a situation or express complaints, suggestions, requests and compliments. The access to the system, called FOCUS, requires previous user registration.

App

ANATEL Consumidor App can be used to report a situation and/or express complaints, suggestions, requests and compliments, through your phone or tablet. A FAQ section on the app can be checked for general queries. The app is available for Android, iOS and Windows Phone and can be downloaded on your App Store for free. The same username can be used for the App and online service.

Android: https://goo.gl/YMBdQS
iOS: https://goo.gl/d5RYtF
Windows Phone: http://goo.gl/SwMFEk

On-site Service

A space called Sala do Cidadão (citizen room) is available in each capital city in Brazil to provide customer service for those who choose not to use the app, online service or phone. Check the addresses and open hours on their website.

Call Center

ANATEL’s call center operates on weekdays from 8h to 20h, except from holidays.  The phone number 1331 is available for those who wish to report a situation and for general queries.

Perguntas Frequentes / FAQ

Available on their website list of frequently asked questions.

___________

Our team has the experience to work as link between you and all the Brazilian Regulatory Agencies and contacting the regulatory agencies is a key factor in sucessifully achieving the best results. In case you have any questions or comments, our team is more than willing to assist you.

Follow us on social media to get an update on the top news regarding the Brazilian regulatory system.

DOMO Salute Team

 

MORE NEWS

07/18/2024
  From June 24 to 28, ANVISA participated in the MDSAP Forum and Regulatory Authority Council (RAC) meeting in Essen, Germany. The event gathered representatives from 27 countries, including regulatory authorities, MDSAP auditing organizations, and industry representatives, with notable attendance from Brazilian associations ABIMED and [...]
07/02/2024
  In force since January 2022, RDC 591/2021, which provides for the Unique Device Identification (UDI) system, was amended by ANVISA just days before the deadline for attributing and affixing UDI to risk class IV devices. The amendment was published in RDC 884/2024 on June 1, 2024, and is already in force. According to ANVISA,... Leia [...]
04/12/2024
Marking a significant advancement in regulatory reliance mechanisms, the National Health Surveillance Agency (ANVISA) published Normative Instruction (IN) 290/2024, on April 8, 2024. This normative introduces an optimized procedure for evaluating and deciding on registration petitions for medical devices previously regulated in recognized [...]
03/22/2024
Important Regulatory Update for Manufacturers under MDSAP in Brazil Today, ANVISA has announced a significant regulatory development with the publication of Resolution RDC 850/2024. This regulation brings forth a crucial amendment concerning the validity period of the Brazilian Good Manufacturing Practices (BGMP) Certificate for manufacturers [...]
01/05/2024
Collegiate Board Resolution (RDC) 837/2023, published by ANVISA on December 15th, 2023, brings updates to the rules regarding clinical investigations with medical devices performed in Brazil. Effective immediately from the publication, this resolution aligns Brazilian practices with international standards, providing clearer guidelines for [...]
12/13/2023
On 11 of December 2023, ANVISA published Collegiate Board Resolution – RDC 830/2023, addressing risk classification, registration procedures, as well as labeling requirements and instructions for use of in vitro diagnostic medical devices (IVDs) in Brazil. The new RDC, effective from June 1, 2024, is a comprehensive revision that consolidates [...]
11/28/2023
Public Consultation No. 1.208 will be open to receive contributions until December 9th. In the dynamic landscape of medical device regulations in Brazil, obtaining the Brazilian Good Manufacturing Practices (BGMP) certification is a mandatory request for manufacturers of Class III and Class IV devices seeking Registro. In a recent move towards [...]
03/01/2023
  Starting today – March 1st 2023 – the new Resolution RDC nº 751/2022  comes into force. The Resolution provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. In order to meet the new requirements and procedures, ANVISA has already [...]
09/22/2022
The Collegiate Board Resolution – RDC 751/2022 was published on the 21st of September 2022, which provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. The new RDC consolidates the risk classification and regularization regimes for all risk [...]